Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07197619 · ClinicalTrials.gov registry record

Effect of Hernia Sac Excision on Crural Tension in Paraesophageal Hernia Repair

A clinical trial of Paraesophageal Hernia, sponsored by Corewell Health West.

Recruiting
Registry status
42
Enrollment target
1
Study location

NCT07197619: Recruiting study of Paraesophageal Hernia, sponsored by Corewell Health West.

NCT07197619 is a study of Paraesophageal Hernia that is actively recruiting participants, run by Corewell Health West. The registered enrollment target is 42 participants, below the 108-participant average among 6 other Paraesophageal Hernia trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07197619, a study of Paraesophageal Hernia, is actively recruiting participants, sponsored by Corewell Health West.

RECRUITING
Registry status
42 participants
Enrollment target
1
Study location

Study Summary

Paraesophageal hernia can cause significant clinical symptoms, including reflux, chest pain, nausea, regurgitation, and even life threatening conditions such as bowel obstruction, and gastric volvulus. Repair of a paraesophageal hernia is associated with significant recurrence rate, with primary repair often in excess of 50%. Hernia recurrence and revisional surgery significantly increase the likelihood of complications and decreased quality of life.

Primary Outcome

Intraoperative Pre and Post hernia sac excision crural tension measurement will be collected.

Conditions Studied

Study Locations (1)

Michigan

  • Corewell Health - Grand Rapids

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2021-08-27
Est. Completion 2026-06
Corewell Health West

38 total trials

What NCT07197619 shows while recruiting

NCT07197619 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 108-participant average among 6 other Paraesophageal Hernia trials with a reported enrollment target (61% lower).

The record links to 1 condition, with Paraesophageal Hernia appearing as the primary indexed condition, and to 0 interventions.

NCT07197619 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT07197619 about?

NCT07197619 is a clinical study titled "Effect of Hernia Sac Excision on Crural Tension in Paraesophageal Hernia Repair". Paraesophageal hernia can cause significant clinical symptoms, including reflux, chest pain, nausea, regurgitation, and even life threatening conditions such as bowel obstruction, and gastric volvulus. Repair of a paraesophageal hernia is associated with significant recurrence rate, with primary rep...

What is the current status of trial NCT07197619?

This trial is currently recruiting. The enrollment target is 42 participants. The study started on 2021-08-27. Estimated completion is 2026-06.

What conditions does trial NCT07197619 study?

This clinical trial studies the following conditions: Paraesophageal Hernia.

Who is sponsoring clinical trial NCT07197619?

This trial is sponsored by Corewell Health West, which has 38 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07197619 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Paraesophageal Hernia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02852213 · 42 participants · Phase 1

    A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients

  • NCT03136146 · 42 participants · Phase 2

    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

  • NCT03178149 · 42 participants · Phase 1

    A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

  • NCT03663530 · 42 participants · NA

    Circadian Misalignment and Energy Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07197619, the US trial registry maintained by the National Library of Medicine. NCT07197619 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.